A double-blinded, randomized controlled trial of oxytocin at the beginning versus the end of the third stage of labor for prevention of postpartum hemorrhage - PubMed (original) (raw)

Clinical Trial

doi: 10.1159/000078095. Epub 2004 Apr 20.

Affiliations

• PMID: 15103233
• DOI: 10.1159/000078095

Clinical Trial

A double-blinded, randomized controlled trial of oxytocin at the beginning versus the end of the third stage of labor for prevention of postpartum hemorrhage

Warner K Huh et al. Gynecol Obstet Invest. 2004.

Abstract

Objective: The objective of this study was to compare the administration of oxytocin at the beginning and end of the third stage of labor for the prevention of postpartum hemorrhage.

Methods: Patients with documented singleton pregnancies were randomly assigned to two groups. The first received 10 units of oxytocin intramuscularly at delivery of the anterior shoulder of the fetus and an identical appearing placebo injection following delivery of the placenta. The second received the opposite medication sequence. The study was double blinded. Blood loss was measured by weighing all fluids collected, visual estimation, and serial blood counts.

Results: 27 women received oxytocin at the delivery of the fetal shoulder and 24 after the placenta. Oxytocin given after placenta delivery resulted in lower blood loss (345 vs. 400 ml, p = 0.28), lower collection bag weight (763 vs. 833 g, p = 0.55), lower change in HgB (-1.26 vs. -1.32 g, p = 0.86), lower DeltaHCT (-3.43 vs. -3.64%, p = 0.85), and a shorter third stage of labor duration (8.6 vs. 9.2 min, p = 0.75). The incidence of postpartum hemorrhage, defined as estimated blood loss >500 ml (0 vs. 14.8%) was significantly lowered with oxytocin following placental delivery (p = 0.049).

Conclusions: In our study, postpartum hemorrhage was less frequent when oxytocin administration was delayed until after placenta delivery.

Copyright 2004 S. Karger AG, Basel

PubMed Disclaimer

Similar articles

• A randomized controlled trial comparing oxytocin administration before and after placental delivery in the prevention of postpartum hemorrhage.
  Jackson KW Jr, Allbert JR, Schemmer GK, Elliot M, Humphrey A, Taylor J. Jackson KW Jr, et al. Am J Obstet Gynecol. 2001 Oct;185(4):873-7. doi: 10.1067/mob.2001.117363. Am J Obstet Gynecol. 2001. PMID: 11641669 Clinical Trial.
• Prevention of postpartum hemorrhage by uterotonic agents: comparison of oxytocin and methylergometrine in the management of the third stage of labor.
  Fujimoto M, Takeuchi K, Sugimoto M, Maruo T. Fujimoto M, et al. Acta Obstet Gynecol Scand. 2006;85(11):1310-4. doi: 10.1080/00016340600756912. Acta Obstet Gynecol Scand. 2006. PMID: 17091409 Clinical Trial.
• The Salford Third Stage Trial. Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labor.
  Mitchell GG, Elbourne DR. Mitchell GG, et al. Online J Curr Clin Trials. 1993 Aug 13;Doc No 83:[2305 words; 32 paragraphs]. Online J Curr Clin Trials. 1993. PMID: 8306013 Review.
• Preventing postpartum hemorrhage: managing the third stage of labor.
  Maughan KL, Heim SW, Galazka SS. Maughan KL, et al. Am Fam Physician. 2006 Mar 15;73(6):1025-8. Am Fam Physician. 2006. PMID: 16570736 Review.

Cited by

• Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
  Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, Williams MJ, Diaz V, Pasquale J, Chamillard M, Widmer M, Tunçalp Ö, Hofmeyr GJ, Althabe F, Gülmezoglu AM, Vogel JP, Oladapo OT, Coomarasamy A. Gallos ID, et al. Cochrane Database Syst Rev. 2018 Dec 19;12(12):CD011689. doi: 10.1002/14651858.CD011689.pub3. Cochrane Database Syst Rev. 2018. PMID: 30569545 Free PMC article.
• Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
  Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gülmezoglu AM, Hofmeyr GJ, Coomarasamy A. Gallos ID, et al. Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD011689. doi: 10.1002/14651858.CD011689.pub2. Cochrane Database Syst Rev. 2018. PMID: 29693726 Free PMC article. Updated. Review.
• Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
  Salati JA, Leathersich SJ, Williams MJ, Cuthbert A, Tolosa JE. Salati JA, et al. Cochrane Database Syst Rev. 2019 Apr 29;4(4):CD001808. doi: 10.1002/14651858.CD001808.pub3. Cochrane Database Syst Rev. 2019. PMID: 31032882 Free PMC article.
• A comparison of misoprostol with and without methylergometrine and oxytocin in outpatient medical abortion: a phase III randomized controlled trial.
  Jahromi AR, Rahmanian V, Taghizadeh H, Zareibabaarabi Z. Jahromi AR, et al. BMC Res Notes. 2023 Oct 5;16(1):257. doi: 10.1186/s13104-023-06509-6. BMC Res Notes. 2023. PMID: 37798748 Free PMC article. Clinical Trial.
• Prophylactic use of ergot alkaloids in the third stage of labour.
  Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM. Liabsuetrakul T, et al. Cochrane Database Syst Rev. 2018 Jun 7;6(6):CD005456. doi: 10.1002/14651858.CD005456.pub3. Cochrane Database Syst Rev. 2018. PMID: 29879293 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • S. Karger AG, Basel, Switzerland